TABLE 3.
Results of univariate and multivariable analysis for DSS
Univariate P value |
Multivariable adjusted HR (95% CI) |
P value | |
---|---|---|---|
Age >54 y | 0.94 | ||
Sex | 0.05 | .929 | |
Male | 1.06 (0.27-4.18) | ||
Female | Ref | ||
BMI >29.3 kg/m2 | 0.458 | ||
Distant metastasis | 0.745 | ||
Adjuvant chemotherapy | 0.862 | ||
Preoperative chemotherapy | 0.803 | ||
Maximum SUV >9.4 | 0.186 | ||
MTV >47.5 mL | 0.623 | ||
TLG >197 SUVlbm*mL | 0.346 | ||
Type of operation | 0.186 | ||
Distant resection | 0.105 | ||
R status | 0.303 | ||
TTR <12 mo | 0.059 | 2.77 (1-7.62) | .049 |
NLR >3.7 | 0.119 | ||
PLR >208.5 | 0.287 | ||
LMR <4 | 0.023 | 4.18 (1.18-14.76) | .027 |
MPV >10.7 | 0.595 | ||
NAR <1.1 | 0.392 |
Abbreviations: BMI, body mass index, CI, confidence interval; DSS, disease-specific survival; HR, hazard ratio; LMR, lymphocyte-to-monocyte ratio; MPV, mean platelet volume; MTV, metabolic tumor volume; NAR, neutrophil-to-albumin ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SUV, standardized uptake value; TLG, total lesion glycolysis; TTR, time to recurrence.